150 related articles for article (PubMed ID: 18541518)
21. Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs.
Evans WK; Nefsky M; Pater J; Browman G; Cowan DH
Chronic Dis Can; 2002; 23(4):152-6. PubMed ID: 12517323
[TBL] [Abstract][Full Text] [Related]
22. [Organisation of clinical research in France: the new missions of inter-regional delegations for clinical research].
Jaillon P
Bull Acad Natl Med; 2008 May; 192(5):929-37; discussion 937-9. PubMed ID: 19238783
[TBL] [Abstract][Full Text] [Related]
23. [Economic burden of cancer in South Korea for the year 2005].
Kim J; Hahm MI; Park EC; Park JH; Park JH; Kim SE; Kim SG
J Prev Med Public Health; 2009 May; 42(3):190-8. PubMed ID: 19491563
[TBL] [Abstract][Full Text] [Related]
24. [The cost of cancer in France: macroeconomic and microeconomic approaches, evolution towards a prospective payment system].
Perrier L; Borella L; Philip T
Bull Cancer; 2003 Nov; 90(11):1005-9. PubMed ID: 14706905
[TBL] [Abstract][Full Text] [Related]
25. Cost of cancer care: the patient perspective.
Kim P
J Clin Oncol; 2007 Jan; 25(2):228-32. PubMed ID: 17210945
[TBL] [Abstract][Full Text] [Related]
26. [Prospects for national health expenditure in Japan].
Sakoi M
Gan To Kagaku Ryoho; 2000 Aug; 27(9):1337-46. PubMed ID: 10969587
[TBL] [Abstract][Full Text] [Related]
27. [Efficiency versus quality in the NHS, in Portugal: methodologies for evaluation].
Giraldes Mdo R
Acta Med Port; 2008; 21(5):397-410. PubMed ID: 19187682
[TBL] [Abstract][Full Text] [Related]
28. The medical expenditure panel survey: a national information resource to support healthcare cost research and inform policy and practice.
Cohen JW; Cohen SB; Banthin JS
Med Care; 2009 Jul; 47(7 Suppl 1):S44-50. PubMed ID: 19536015
[TBL] [Abstract][Full Text] [Related]
29. Innovative cancer therapies: putting costs into context.
Khayat D
Cancer; 2012 May; 118(9):2367-71. PubMed ID: 21918962
[TBL] [Abstract][Full Text] [Related]
30. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
[TBL] [Abstract][Full Text] [Related]
31. Medical doctors profile in Ethiopia: production, attrition and retention. In memory of 100-years Ethiopian modern medicine & the new Ethiopian millennium.
Berhan Y
Ethiop Med J; 2008 Jan; 46 Suppl 1():1-77. PubMed ID: 18709707
[TBL] [Abstract][Full Text] [Related]
32. Pharmacoeconomics of lipid lowering therapy in Ireland.
Barry M; Heerey A; Sheehan O; Ryan M; McCulloch D; Feely J
Ir Med J; 1999; 92(7):430-2. PubMed ID: 10967865
[TBL] [Abstract][Full Text] [Related]
33. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
[TBL] [Abstract][Full Text] [Related]
34. [Costs of initial cancer care and its affecting factors].
Kim SY; Kim SG; Park JH; Park EC
J Prev Med Public Health; 2009 Jul; 42(4):243-50. PubMed ID: 19675401
[TBL] [Abstract][Full Text] [Related]
35. [Why drug prices are high in sub-Saharan Africa. Analysis of price structure: the case of Senegal].
Guimier JM; Candau D; Garenne M; Teulières L
Sante; 2005; 15(1):41-52. PubMed ID: 15919632
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
[TBL] [Abstract][Full Text] [Related]
37. [Volume and costs of the hospital management of cancer in France in 1999].
Borella L; Finkel S; Crapeau N; Peuvrel P; Sauvage M; Perrier L; Lepage E; Villeminot J; Garrigues B
Bull Cancer; 2002 Sep; 89(9):809-21. PubMed ID: 12368133
[TBL] [Abstract][Full Text] [Related]
38. [The "Plan Cancer" in France: an economists' point of view].
Moatti JP; Le Corroller Soriano AG; Protière C
Bull Cancer; 2003 Nov; 90(11):1010-5. PubMed ID: 14706906
[TBL] [Abstract][Full Text] [Related]
39. Free drugs in clinical trials and their potential cost saving impact on the National Health Service: a retrospective cost analysis in Italy.
Grossi F; Genova C; Gaitan ND; Dal Bello MG; Rijavec E; Barletta G; Sini C; Donato C; Beltramini S; Pronzato P; Porcile G; Boccardo F; Walzer S
Lung Cancer; 2013 Aug; 81(2):236-40. PubMed ID: 23648072
[TBL] [Abstract][Full Text] [Related]
40. The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000-2009.
Lichtenberg FR
Econ Hum Biol; 2014 Mar; 13():107-27. PubMed ID: 23664114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
